Cargando…
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
The discovery and development of small molecule cancer drugs has been revolutionised over the last decade. Most notably, we have moved from a one‐size‐fits‐all approach that emphasized cytotoxic chemotherapy to a personalised medicine strategy that focuses on the discovery and development of molecul...
Autores principales: | Hoelder, Swen, Clarke, Paul A., Workman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476506/ https://www.ncbi.nlm.nih.gov/pubmed/22440008 http://dx.doi.org/10.1016/j.molonc.2012.02.004 |
Ejemplares similares
-
Discovery of Novel Small-Molecule
Inhibitors of BRD4
Using Structure-Based Virtual Screening
por: Vidler, Lewis R., et al.
Publicado: (2013) -
Drug discovery in ophthalmology: past success, present challenges, and future opportunities
por: Gower, Nicholas J. D., et al.
Publicado: (2016) -
Challenges and Opportunities for Small Molecule Aptamer Development
por: McKeague, Maureen, et al.
Publicado: (2012) -
Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023) -
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies
por: Blanco-González, Alexandre, et al.
Publicado: (2023)